Write your message
Volume 7, Issue 6 (November - December 2022)                   J Obstet Gynecol Cancer Res 2022, 7(6): 563-568 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ubaid Hamza M, M. Hameed N, Hasan Al-Zubaidi S, Abulkassim R, Basim Mohamed Z, Saad Mahmood S, et al . Toxoplasma Gondii Seroprevalence Among Pregnant Women in Baghdad During 2021-2022. J Obstet Gynecol Cancer Res. 2022; 7 (6) :563-568
URL: http://jogcr.com/article-1-731-en.html
1- Medical Technical College, Al-Farahidi University, Baghdad, Iraq , ubaid.hamza1@YAHOO.COM
2- Al–Nisour University College, Baghdad, Iraq
3- Department of Anesthesia Techniques, Al-Mustaqbal University College, Babylon, Iraq
4- Al-Manara College for Medical Sciences, Misan, Iraq
5- Department of Pharmacy, Ashur University College, Baghdad, Iraq
6- Al-Esraa University College, Baghdad, Iraq
7- The Islamic University, Najaf, Iraq
8- Altoosi University College, Najaf, Iraq
9- Department of Nursing, Al-Zahrawi University College, Karbala, Iraq
10- Department of Nursing, Hilla University College, Babylon, Iraq
Abstract:   (206 Views)

Background & Objective: Toxoplasmosis is a zoonotic infection caused by Toxoplasma gondii, a parasite that causes a variety of clinical symptoms in humans. It is a facultatively heteroxenous, polyxenous protozoon that has evolved several potential transmission routes within and between the host species. Infections caused by Toxoplasma gondii are more frequently seen in immunocompetent patients. The infection acquired by the mother during pregnancy puts the fetus at risk of congenital infection due to the parasite transmission across the placenta. The severity and frequency of infection are determined by the gestational age of the mother at the time of infection. The objective of this research was to study the toxoplasmosis infection in women, and to estimate the relationship between T. gondii infection and parameters including abortion time, chronic diseases, and age.
Materials & Methods: The case-control study was conducted on 50 healthy women (pregnant and non-pregnant) as control group and 135 women with abortion experience as case group at the Women's and Children's Hospital in Baghdad, Iraq from December 2021 until March 2022. The questionnaire was used to gather information from the women. The participant's name, age, gestational age, address, medications taken, medical history, previous abortions, and the date the sample was taken were all included. Under sterile conditions, five milliliters of the venous blood were drawn from each woman. The ELISA test was used to determine the level of anti-T. gondii IgM and IgG antibodies in serum samples.
Results: The anti-Toxoplasma IgM and IgG antibodies were found to be positive in 51% and 8% of the cases, respectively. However, the anti-T. gondii antibodies seroprevalence was 59% in women who had abortion.  The healthy women had 0% for all antibodies.
Conclusion: Despite reporting the high rates of infection among women who had single abortions, the current study found no significant association between the percentage of infection and the number of abortions. The cause of high incidence among women who had abortion could be due to decrease in the immune system function.

     
Systematic Review: Original Research | Subject: Obstetrics and Gynecology
Received: 2022/06/6 | Accepted: 2022/07/27 | Published: 2022/09/9

References
1. Abdulai-Saiku S, Tong WH, Vyas A. Behavioral manipulation by Toxoplasma gondii: does brain residence matter? Trends Parasitol. 2021;37(5):381-90. [DOI:10.1016/j.pt.2020.12.006] [PMID]
2. Marangi M, Lago N, Mancinelli G, Antonio OL, Scirocco T, Sinigaglia M, et al. Occurrence of the protozoan parasites Toxoplasma gondii and Cyclospora cayetanensis in the invasive Atlantic blue crab Callinectes sapidus from the Lesina Lagoon (SE Italy). Marine Pollution Bulletin. 2022;176:113428. [DOI:10.1016/j.marpolbul.2022.113428] [PMID]
3. Zhao W, Yu H, Liu X, Wang T, Yao Y, Zhou Q, et al. Systematic identification of the lysine lactylation in the protozoan parasite Toxoplasma gondii. Parasites Vectors. 2022;15(1):1-14. [DOI:10.1186/s13071-022-05315-6] [PMID] [PMCID]
4. Spalenka J, Escotte-Binet S, Bakiri A, Hubert J, Renault J-H, Velard F, et al. Discovery of new inhibitors of Toxoplasma gondii via the pathogen box. Antimicrob Agents Chemother. 2018;62(2):e01640-17. [DOI:10.1128/AAC.01640-17] [PMID] [PMCID]
5. Fecková M, Antolová D, Janičko M, Monika H, Štrkolcová G, Goldová M, et al. The cross-sectional study of Toxoplasma gondii seroprevalence in selected groups of population in Slovakia. Folia Microbiol. 2020;65(5):871-7. [DOI:10.1007/s12223-020-00797-2] [PMID]
6. Safronova A, Araujo A, Camanzo ET, Moon TJ, Elliott MR, Beiting DP, et al. Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii. Nat Immunol. 2019;20(1):64-72. [DOI:10.1038/s41590-018-0250-8] [PMID] [PMCID]
7. Šimeková K, Nováková E, Rosoľanka R, Masná J, Antolová D. Clinical course of opportunistic infections-toxoplasmosis and cytomegalovirus infection in HIV-infected patients in Slovakia. Pathogens. 2019;8(4):219. [DOI:10.3390/pathogens8040219] [PMID] [PMCID]
8. Al-Adhroey AH, Mehrass AA-KO, Al-Shammakh AA, Ali AD, Akabat MYM, Al-Mekhlafi HM. Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen. BMC Infect Dis. 2019;19(1):1-9. [DOI:10.1186/s12879-019-4718-4] [PMID] [PMCID]
9. Zhou Z, Lopez HIAO, Pérez GE, Burgos LM, Farina JM, Saldarriaga C, et al. Toxoplasmosis and the Heart. Curr Probl Cardiol. 2021;46(3):100741. [DOI:10.1016/j.cpcardiol.2020.100741] [PMID]
10. Montazeri M, Mikaeili Galeh T, Moosazadeh M, Sarvi S, Dodangeh S, Javidnia J, et al. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967-2017): a systematic review and meta-analysis. Parasites Vectors. 2020;13(1):1-10. [DOI:10.1186/s13071-020-3954-1] [PMID] [PMCID]
11. Amouei A, Sarvi S, Sharif M, Aghayan SA, Javidnia J, Mizani A, et al. A systematic review of Toxoplasma gondii genotypes and feline: Geographical distribution trends. Transbound Emerg Dis. 2020;67(1):46-64. [DOI:10.1111/tbed.13340] [PMID]
12. Smith NC, Goulart C, Hayward JA, Kupz A, Miller CM, Van Dooren GG. Control of human toxoplasmosis. Int J Parasitol. 2021;51(2-3):95-121. [DOI:10.1016/j.ijpara.2020.11.001] [PMID]
13. Fallahi S, Rostami A, Shiadeh MN, Behniafar H, Paktinat S. An updated literature review on maternal-fetal and reproductive disorders of Toxoplasma gondii infection. J Gynecol Obstet Hum Reprod. 2018;47(3):133-40. [DOI:10.1016/j.jogoh.2017.12.003] [PMID]
14. Ahmed M, Sood A, Gupta J. Toxoplasmosis in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2020;255:44-50. [DOI:10.1016/j.ejogrb.2020.10.003] [PMID]
15. Fürnkranz U, Walochnik J. Nosocomial infections: Do not forget the parasites! Pathogens. 2021;10(2):238. [DOI:10.3390/pathogens10020238] [PMID] [PMCID]
16. Bokharaei-Salim F, Esteghamati A, Khanaliha K, Kalantari S, Sayyahfar S, Donyavi T, et al. Evaluation of a PCR assay for diagnosis of toxoplasmosis in serum and peripheral blood mononuclear cell among HIV/AIDS patients. J Parasit Dis. 2020;44(1):159-65. [DOI:10.1007/s12639-019-01176-6] [PMID] [PMCID]
17. Odeniran PO, Omolabi KF, Ademola IO. Risk factors associated with seropositivity for Toxoplasma gondii in population-based studies among immunocompromised patients (pregnant women, HIV patients and children) in West African countries, Cameroon and Gabon: a meta-analysis. Acta Trop. 2020;209:105544. [DOI:10.1016/j.actatropica.2020.105544] [PMID]
18. Owusu-Dommey A, Pogreba-Brown K, Villa-Zapata L. Seroprevalence of Toxoplasma gondii in the US: Evidence from a representative cross-sectional survey. Int J Parasitol. 2020;79:102175. [DOI:10.1016/j.parint.2020.102175] [PMID]
19. Mareze M, Benitez AdN, Brandão APD, Pinto-Ferreira F, Miura AC, Martins FDC, et al. Socioeconomic vulnerability associated to Toxoplasma gondii exposure in southern Brazil. PLoS One. 2019;14(2):e0212375. [DOI:10.1371/journal.pone.0212375] [PMID] [PMCID]
20. Achaw B, Tesfa H, Zeleke AJ, Worku L, Addisu A, Yigzaw N, et al. Sero-prevalence of Toxoplasma gondii and associated risk factors among psychiatric outpatients attending University of Gondar Hospital, Northwest Ethiopia. BMC Infectious Diseases. 2019;19(1):1-8. [DOI:10.1186/s12879-019-4234-6] [PMID] [PMCID]
21. Sander V, Angel SO, Clemente M. A comprehensive review of Toxoplasma gondii biology and host-cell interaction: challenges for a plant-based vaccine. Prospects plant-based vaccines veterinary med. 2018:89-120. [DOI:10.1007/978-3-319-90137-4_4]
22. Abdelbaset AE, Abushahba MFN, Igarashi M. Toxoplasma gondii in humans and animals in Japan: An epidemiological overview. Parasitol Int. 2021;87:102533. [DOI:10.1016/j.parint.2021.102533] [PMID]
23. Al-Awadi AAH, Abdul‑Ghani R, Al-Mekhlafi AM. Toxoplasma gondii Infection Among Institutionalized Children with Down syndrome in Sana'a city, Yemen: Implications of Low IgG Seroprevalence. Acta Parasitol. 2022;67(1):530-4. [DOI:10.1007/s11686-021-00473-6] [PMID] [PMCID]
24. Alsailawi HA, Ayat SS, Mudhafar M, Mohammed RK, Dhahi SJ, Abdulrasool MM, et al. Immunohistochemical study of TGF-β, PDL-1, and IL-10 in patients with Toxoplasma gondii. Na J Adv Res Rev. 2022;14(1):436-48. [DOI:10.30574/wjarr.2022.14.1.0346]
25. Kheirandish F, Ezatpour B, Fallahi S, Tarahi MJ, Hosseini P, Rouzbahani AK, et al. Toxoplasma serology status and risk of miscarriage, a case-control study among women with a history of spontaneous abortion. Int J Fertil Steril. 2019;13(3):184-9.
26. Mohammed LJ, Al-Janabi MS. Seroprevalence of toxoplasmosis in aborted women in Babylon Province, Iraq. Medical Journal of Babylon. 2019;16(3):188-91. [DOI:10.4103/MJBL.MJBL_26_19]
27. Gelaye W, Kebede T, Hailu A. High prevalence of anti-toxoplasma antibodies and absence of Toxoplasma gondii infection risk factors among pregnant women attending routine antenatal care in two Hospitals of Addis Ababa, Ethiopia. Int J Infect Dis. 2015;34:41-5. [DOI:10.1016/j.ijid.2015.03.005] [PMID]
28. Nazari N, Bozorgomid A, Janbakhsh A, Bashiri F. Toxoplasma gondii and human immunodeficiency virus co-infection in western Iran: A cross sectional study. Asian Pac J Trop Med. 2018;11(1):58-62. [DOI:10.4103/1995-7645.223562]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.